4.7 Article

Utility of repeat extractable nuclear antigen antibody testing: a retrospective audit

期刊

RHEUMATOLOGY
卷 62, 期 3, 页码 1248-1253

出版社

OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/keac437

关键词

Autoantibodies; repeat testing; extractable nuclear antigen; ENA; utilization; unnecessary

向作者/读者索取更多资源

The utility of repeat ENA testing after an initial negative result was assessed in this study. A retrospective study was conducted in a single, multicentre tertiary health network in Melbourne, Australia. The results showed that repeat ENA test results rarely change or result in a new diagnosis of an ANA-associated rheumatic disease (AARD), with repeated testing only warranted if there is a change in clinical manifestations.
Objectives Autoantibodies to ENA are frequently ordered during the workup of suspected autoimmune connective tissue diseases. There are no current guidelines for repeat test ordering. The objective of this study was to assess the utility of repeat ENA testing after an initial negative result. Methods A retrospective study was conducted in a single, multicentre tertiary health network in Melbourne, Australia. Results of all ENA tests were extracted from the hospital laboratory information system. For patients who had a change in ENA result from negative to positive, clinical information was obtained from the hospital records regarding new diagnosis of an ANA-associated rheumatic disease (AARD). Results A total of 23 438 ENA tests were performed in 19 603 patients from 29 July 2013 to 28 September 2020. In total, 20 918 (89.2%) were negative with 215 (0.9%) being equivocal. Of the 2305 positive tests, the most common ENA auto-antibody specificity detected was anti-Ro52 (1185, 51.4%). A total of 2636 of 19 603 patients (13.4%) had more than one ENA test performed during the study period. Of these, most (2523, 95.7%) had stable ENA results with no change compared with the first test. Only 53 patients (2.2%) had an ENA result that changed from negative to positive. Excluding patients with pre-existing rheumatic conditions and those under 18, there were five new AARDs found in the remaining 34 patients. Conclusion Repeat ENA test results rarely change or result in a new diagnosis of an AARD, with repeated testing only warranted if there is a change in clinical manifestations.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据